Back
EyePoint Pharmaceuticals Stock Predictions
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
63
EYPT
EyePoint Pharmaceuticals
Last Price:
8.92
Seasonality Move:
-10.5%
7 Day Trial
ALL ACCESS PASS
$
7
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.EyePoint Pharmaceuticals Stock Forecast
- Over the next 52 weeks, EyePoint Pharmaceuticals has on average historically fallen by 2.7% based on the past 19 years of stock performance.
- EyePoint Pharmaceuticals has fallen lower in 11 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.89%
-
Is EyePoint Pharmaceuticals Stock Undervalued?
The current EyePoint Pharmaceuticals [EYPT] share price is $8.78. The Score for EYPT is 63, which is 26% above its historic median score of 50, and infers lower risk than normal. - EYPT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will EyePoint Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, EyePoint Pharmaceuticals has on average historically fallen by 2.7% based on the past 19 years of stock performance.
EyePoint Pharmaceuticals Stock Rating
Buy
63
EyePoint Pharmaceuticals (EYPT)
is a Buy
Is EyePoint Pharmaceuticals overpriced?
- EyePoint Pharmaceuticals has fallen lower in 11 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.89%
EyePoint Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
eyepointpharma.com
52-Week Data
52-Week High:
30.99
52-Week Low:
5.67
Prediction Charts
Market Cap:
469.89M
Price in USD:
8.78
Volume:
456.15K
Beta:
1.93
Technical Analysis
SMA50:
8.89
SMA100:
10.05
SMA200:
16.40
52-Wk Change:
-16.22%
Stock Predictions
-
Is EyePoint Pharmaceuticals stock public?
Yes, EyePoint Pharmaceuticals is a publicly traded company. -
What is the EyePoint Pharmaceuticals stock quote today?
The EyePoint Pharmaceuticals stock price is 8.78 USD today. -
How to buy EyePoint Pharmaceuticals stock online?
You can buy EyePoint Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Aug-28 | 9.40 | 8.82 | 9.57 | 8.76 |
| Aug-29 | 8.91 | 8.72 | 9.09 | 8.71 |
| Aug-30 | 8.75 | 8.95 | 9.06 | 8.58 |
| Sep-3 | 8.82 | 8.15 | 8.94 | 8.08 |
| Sep-4 | 8.15 | 8.36 | 8.56 | 8.10 |
| Sep-5 | 8.31 | 8.05 | 8.54 | 8.04 |
| Sep-6 | 8.06 | 7.99 | 8.21 | 7.72 |
| Sep-9 | 8.00 | 8.24 | 8.53 | 7.94 |
| Sep-10 | 8.24 | 8.03 | 8.35 | 7.61 |
| Sep-11 | 8.00 | 8.22 | 8.35 | 7.90 |
| Sep-12 | 8.23 | 8.88 | 9.09 | 8.17 |
| Sep-13 | 9.01 | 9.10 | 9.72 | 8.99 |
| Sep-16 | 9.15 | 8.84 | 9.49 | 8.80 |
| Sep-17 | 8.92 | 8.78 | 9.12 | 8.70 |
EyePoint Pharmaceuticals Earnings
EyePoint Pharmaceuticals Earnings Report: Per Share EyePoint Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
EyePoint Pharmaceuticals Forecast Revenue Growth
EyePoint Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for EyePoint Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.21 per share, a decrease this year of $0.42 per share, and a decrease next year of $0.94 per share.
* EyePoint Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.